{"meta":{"query_hash":"a3f01cd76920","filters":{"venue":"Experimental and Molecular Therapeutics"},"cohort_total":10,"direct_labels_cover":0,"predictions_cover":10,"exported":10,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a3f01cd76920","api":"https://metacan.xera.ac/api/v1/cohort?venue=Experimental+and+Molecular+Therapeutics"},"results":[{"id":"W2953614913","doi":"10.1158/1538-7445.sabcs18-2988","title":"Abstract 2988: Quantifying the Uptake of Metal Based Cancer Therapy Drugs Using Single Cell ICP-MS","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Analytical chemistry methods development","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PerkinElmer Biosignal","funders":"","keywords":"Population; Cell; Cancer; Cancer cell; Drug; Computational biology; Cancer therapy; Drug discovery; Chemistry; Cancer research; Biology; Medicine; Bioinformatics; Pharmacology; Internal medicine; Biochemistry","score_opus":0.07683960953897799,"score_gpt":0.34104471455793817,"score_spread":0.26420510501896016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953614913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985575,0.0080058975,0.0012274199,0.00006046993,0.00007314434,0.00011551803,0.000009534305,0.000023415818,0.004909604],"genre_scores_gemma":[0.99331087,0.000070899594,0.005911647,0.0004338408,0.000026692976,0.000011642627,0.000008306459,0.000043513894,0.0001826143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874616,0.00002504085,0.00032512055,0.0003098337,0.00032815745,0.00026566588],"domain_scores_gemma":[0.99934584,0.00006283479,0.00015296186,0.00033082548,0.00004008446,0.000067433786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016151016,0.00025120119,0.00026063673,0.000020203768,0.00007849119,0.00003751418,0.00021670235,0.00011064356,0.0011348383],"category_scores_gemma":[0.0000025744816,0.0001861899,0.00014564596,0.00008734255,0.00013205905,0.000040715342,0.00006666053,0.0001755059,0.0000044750905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006939127,0.0002245356,0.00022894939,0.000063923486,0.0001405927,0.000003640665,0.00058511255,0.00004542339,0.9955936,0.000032365857,0.000001047508,0.0030113878],"study_design_scores_gemma":[0.00077419775,0.00002341229,0.00004622878,0.000043397667,0.00004158755,0.0000023698958,0.0013283297,0.0022637364,0.9915984,0.000023227782,0.0036215507,0.00023354679],"about_ca_topic_score_codex":0.00005038011,"about_ca_topic_score_gemma":2.4999434e-7,"teacher_disagreement_score":0.007934998,"about_ca_system_score_codex":0.00008288732,"about_ca_system_score_gemma":0.00007497961,"threshold_uncertainty_score":0.9997783},"labels":[],"label_agreement":null},{"id":"W2954084282","doi":"10.1158/1538-7445.sabcs18-2102","title":"Abstract 2102: Assessing glioma-protein inhibition in sunitinib-resistance using a 3-dimentional tissue-engineered renal cell carcinoma patient derived model","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sunitinib; Renal cell carcinoma; Cancer research; Glioma; Medicine; Internal medicine","score_opus":0.022830930945331302,"score_gpt":0.28054517261782064,"score_spread":0.25771424167248935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954084282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941213,0.004141079,0.00047959166,0.0000796714,0.00003955416,0.0006122507,0.000011628235,0.000020982985,0.0004939507],"genre_scores_gemma":[0.9958751,0.0000049270875,0.003727774,0.00021393574,0.000012988605,0.000048626902,0.00006695314,0.000034811965,0.000014861557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988985,0.000029732442,0.00026745463,0.00029687834,0.00026221693,0.00024521296],"domain_scores_gemma":[0.99961376,0.000010395127,0.00008284493,0.0001630386,0.00003765768,0.00009232097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047971942,0.00022039475,0.00022549264,0.00012766488,0.00006222951,0.000049950046,0.000025549105,0.00008640121,0.000045399785],"category_scores_gemma":[0.0000011291077,0.00021027446,0.000069711685,0.00011305282,0.000037928854,0.00010649002,0.00003686794,0.00011130405,0.0000054967795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010902379,0.00076139346,0.000032838718,0.000041487558,0.000035978956,0.00039024194,0.0003936309,0.00029706676,0.9975551,0.0001809157,0.0000018276703,0.00020052872],"study_design_scores_gemma":[0.002981677,0.00017813359,0.0012677531,0.0001832151,0.000040774685,0.000039701503,0.00045176278,0.00069546874,0.9938352,0.000084558174,0.000035318633,0.00020644684],"about_ca_topic_score_codex":0.00003322435,"about_ca_topic_score_gemma":0.0000018784712,"teacher_disagreement_score":0.0041361516,"about_ca_system_score_codex":0.00014685409,"about_ca_system_score_gemma":0.000054286225,"threshold_uncertainty_score":0.8574744},"labels":[],"label_agreement":null},{"id":"W2954925281","doi":"10.1158/1538-7445.sabcs18-2998","title":"Abstract 2998: Co-targeting bulk tumor and CSCs in clinically translatable TNBC patient-derived xenografts via combination nanotherapy","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Triple-negative breast cancer; Cancer research; Wnt signaling pathway; Medicine; Cancer stem cell; Breast cancer; Cancer; Paclitaxel; Medulloblastoma; Chemistry; Internal medicine; Signal transduction","score_opus":0.011270262596893278,"score_gpt":0.30375400375247347,"score_spread":0.2924837411555802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954925281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891674,0.009804731,0.00008760085,0.000070668226,0.0000682616,0.00045474528,0.0000150771475,0.0000093612725,0.0003221725],"genre_scores_gemma":[0.99818295,0.00055831624,0.00026926308,0.00074976846,0.000019608644,0.000036894704,0.00013266806,0.000030376026,0.00002015611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891263,0.00005187085,0.00023918295,0.0003574747,0.00016012942,0.00027869045],"domain_scores_gemma":[0.9996485,0.000010493988,0.00006541576,0.00016221277,0.000023639193,0.000089704634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009707743,0.00018453326,0.00016399712,0.000042023043,0.00006214424,0.000050610826,0.000076987744,0.000088860535,0.000030837487],"category_scores_gemma":[0.000002364569,0.00017403555,0.000057058638,0.000048472943,0.00008263766,0.000011647004,0.000040773033,0.00009864536,0.0000054840375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040759184,0.0003303489,0.004836002,0.000014163269,0.00008494746,0.000021464919,0.00033792353,0.0000034149189,0.9878414,0.000015122938,0.00001061297,0.0060969833],"study_design_scores_gemma":[0.0027955424,0.0012829117,0.0017561093,0.000018440698,0.000006802144,0.000010891992,0.00024077816,0.00006829893,0.9883614,0.00005500933,0.005190707,0.00021308877],"about_ca_topic_score_codex":0.00009631319,"about_ca_topic_score_gemma":0.000009350618,"teacher_disagreement_score":0.009246415,"about_ca_system_score_codex":0.000020304284,"about_ca_system_score_gemma":0.00003200294,"threshold_uncertainty_score":0.70969635},"labels":[],"label_agreement":null},{"id":"W4229834853","doi":"10.1158/1538-7445.sabcs18-3043","title":"Abstract 3043: Examination of NMT1 and NMT2 as independent prognostic markers and novel drug targets in adult acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Myeloid leukemia; Viability assay; Peripheral blood mononuclear cell; Biology; Context (archaeology); Flow cytometry; Myeloid; Cancer research; Leukemia; Apoptosis; Molecular biology; Immunology; In vitro; Biochemistry","score_opus":0.005465107945958638,"score_gpt":0.2371297582751926,"score_spread":0.23166465032923395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229834853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955417,0.003136168,0.000136099,0.00006172388,0.000056687604,0.00037881316,0.000008678232,0.00000526483,0.00067484507],"genre_scores_gemma":[0.9986269,0.00041192133,0.00032033474,0.00039793417,0.000013108002,0.000020860281,0.000054083543,0.000017736498,0.00013711156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922204,0.000032205964,0.00018293451,0.0002850891,0.00013753597,0.00014016626],"domain_scores_gemma":[0.9996975,0.000007516696,0.00007792784,0.00012474111,0.000035251953,0.000057080128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109365275,0.00015377068,0.00012889293,0.000050194758,0.00002783867,0.00002288621,0.0000592376,0.000107538166,0.000009795376],"category_scores_gemma":[0.000007953032,0.00014776361,0.000027589427,0.000042089934,0.00008530985,0.00001234986,0.00008906575,0.00007898933,0.0000012092027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093308125,0.00007674311,0.0019211556,0.000023893454,0.000057918725,0.0000034109664,0.00030143152,0.0000016188892,0.9944349,0.00030408995,0.0000061148025,0.0027754325],"study_design_scores_gemma":[0.0013609169,0.00026239513,0.02495015,0.000033362376,0.000014292035,0.000019610246,0.00064011005,0.0001280372,0.97190773,0.000030830404,0.00047618893,0.0001763858],"about_ca_topic_score_codex":0.000038159764,"about_ca_topic_score_gemma":0.000005229092,"teacher_disagreement_score":0.023028994,"about_ca_system_score_codex":0.000020164422,"about_ca_system_score_gemma":0.000030926723,"threshold_uncertainty_score":0.6025625},"labels":[],"label_agreement":null},{"id":"W4234797906","doi":"10.1158/1538-7445.sabcs18-1282","title":"Abstract 1282: Understanding the kinomic contributions to tyrosine kinase inhibitor resistance in triple negative breast cancer","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Triple-negative breast cancer; Cancer research; Tyrosine-kinase inhibitor; Breast cancer; Tyrosine kinase; Cancer; Medicine; Internal medicine; Receptor","score_opus":0.01660489894003939,"score_gpt":0.29726831005964294,"score_spread":0.2806634111196035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234797906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842577,0.012333859,0.00077230256,0.0013459538,0.0002083143,0.00045161296,0.00016246716,0.0000068175214,0.0004609893],"genre_scores_gemma":[0.99727213,0.0002605087,0.00007476115,0.0019810952,0.000098652104,0.00007071581,0.000019472893,0.00002287604,0.00019979714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991772,0.000037378923,0.00015755818,0.00029124442,0.000104391016,0.00023218217],"domain_scores_gemma":[0.9996388,0.000010122462,0.000049634997,0.00020399064,0.000033758497,0.00006370373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088778375,0.00016015668,0.00013015691,0.000031001604,0.00009668823,0.000037448488,0.0001134767,0.00008207115,0.00004154357],"category_scores_gemma":[0.0000030417723,0.00012574502,0.000068688816,0.000102384394,0.00007845471,0.0000059844374,0.00007763989,0.000072018425,0.0000055892424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002991023,0.000063399406,0.0012110397,0.0000056565605,0.000054385742,0.0000028989652,0.0002609746,0.000030959913,0.9965218,0.0011644672,0.0002131727,0.0001721586],"study_design_scores_gemma":[0.0013813198,0.000104382605,0.008031718,0.000053789427,0.000015252018,0.0000045976035,0.001147981,0.000024752453,0.9817651,0.00018446629,0.0070319693,0.00025465596],"about_ca_topic_score_codex":0.00007052744,"about_ca_topic_score_gemma":0.00010097484,"teacher_disagreement_score":0.014756668,"about_ca_system_score_codex":0.0001401059,"about_ca_system_score_gemma":0.000055870998,"threshold_uncertainty_score":0.51277333},"labels":[],"label_agreement":null},{"id":"W4237965765","doi":"10.1158/1538-7445.sabcs18-3854","title":"Abstract 3854: Preclinical characterization of a novel non-cyclic dinucleotide small molecule STING agonist with potent antitumor activity in mice","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Sting; Stimulator of interferon genes; Innate immune system; Immune system; Agonist; Biology; Medicine; Cancer research; Immunology; Cell biology; Receptor; Internal medicine","score_opus":0.02129384660175684,"score_gpt":0.27429051234084467,"score_spread":0.25299666573908786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237965765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978467,0.0006270863,0.0005064993,0.00006663688,0.00010914419,0.00033721208,0.000013801682,0.000014648549,0.00047823976],"genre_scores_gemma":[0.99932325,0.00002794248,0.00010916729,0.00022959716,0.0000041836556,0.00001136478,0.00003487671,0.000022637794,0.00023697811],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917054,0.000066211294,0.0002453237,0.0002565517,0.000039460767,0.00022188427],"domain_scores_gemma":[0.9996209,0.000034919638,0.00014418199,0.00015787427,0.000025086372,0.000017016402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010044037,0.00017674117,0.00026687104,0.00006626664,0.000045516834,0.00001731785,0.00011027474,0.00011446214,0.00004930056],"category_scores_gemma":[0.0000040579653,0.0001498818,0.000058397654,0.000064747124,0.000138413,0.00006189602,0.00007247712,0.00020387684,0.000021393544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013175139,0.000742394,0.0010130126,0.000023509356,0.000106449,0.0000070422875,0.00044454972,0.0000022546292,0.99535733,0.000042188713,4.0738817e-7,0.00094334583],"study_design_scores_gemma":[0.0021330381,0.0006119742,0.043679748,0.000104504135,0.000015758274,0.000032792606,0.00024032351,0.000065061315,0.95265883,6.6501354e-7,0.0002864954,0.00017080652],"about_ca_topic_score_codex":0.00008060772,"about_ca_topic_score_gemma":0.0000044148246,"teacher_disagreement_score":0.0426985,"about_ca_system_score_codex":0.000025491116,"about_ca_system_score_gemma":0.000036069734,"threshold_uncertainty_score":0.6112002},"labels":[],"label_agreement":null},{"id":"W4240718667","doi":"10.1158/1538-7445.sabcs18-2699","title":"Abstract 2699: Targeting an ubiquitin-activating enzyme in small-cell lung cancer (SCLC)","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Etoposide; Cancer research; Lung cancer; Cisplatin; Cancer; Cell culture; Medicine; Viability assay; Chemotherapy; Cancer cell; Cell; Biology; Oncology; Internal medicine; Genetics","score_opus":0.02517772543423411,"score_gpt":0.3542647523675444,"score_spread":0.32908702693331027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240718667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967117,0.028917512,0.000030219586,0.00027639815,0.00009794619,0.0005871929,0.0000038465387,0.00003705255,0.0029328244],"genre_scores_gemma":[0.9975818,0.0003264829,0.00049686927,0.0012222225,0.00007733932,0.00007382389,0.00001287007,0.000044694458,0.00016391677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880135,0.000042274467,0.00020818779,0.00034063647,0.00022303773,0.00038453267],"domain_scores_gemma":[0.99957615,0.000027208771,0.000060493567,0.00018410405,0.000038554117,0.00011347504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014287699,0.00019750347,0.00025212296,0.00007113424,0.000069701135,0.000035677585,0.00008289995,0.000068382324,0.00013683237],"category_scores_gemma":[0.0000048218367,0.00017299425,0.000050941464,0.00010483736,0.00005761203,0.000088324894,0.00010120208,0.00026171075,0.0000048410225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014043493,0.00021046861,0.014621325,0.00012834763,0.00008681076,0.00006986049,0.0030896766,0.000016057313,0.9796922,0.000048476104,0.00001610534,0.0018801874],"study_design_scores_gemma":[0.0019467447,0.0002939091,0.0049156887,0.0001765187,0.000020328736,0.0000073510123,0.0037188446,0.00094700174,0.9864254,0.0000100757225,0.0013175791,0.00022058336],"about_ca_topic_score_codex":0.00034104675,"about_ca_topic_score_gemma":0.000010835233,"teacher_disagreement_score":0.030464774,"about_ca_system_score_codex":0.00018260794,"about_ca_system_score_gemma":0.00007944416,"threshold_uncertainty_score":0.70545006},"labels":[],"label_agreement":null},{"id":"W4241004874","doi":"10.1158/1538-7445.sabcs18-4805","title":"Abstract 4805: Cannabinoid WIN 55,212-2 induces endoplasmic reticulum stress in prostate cancer cells through CB<sub>1</sub>and CB2receptors","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"DU145; Cannabinoid receptor; AM251; Cannabinoid; Cannabinoid receptor type 2; Unfolded protein response; Cannabinoid Receptor Agonists; Endoplasmic reticulum; Receptor; Apoptosis; Chemistry; Cancer cell; Prostate cancer; Cancer research; Cell biology; Endocrinology; Internal medicine; Biology; Cancer; Medicine; Antagonist; LNCaP; Biochemistry","score_opus":0.006574682594756684,"score_gpt":0.24903899731229248,"score_spread":0.2424643147175358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241004874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98230565,0.015950343,0.000006527273,0.00015622085,0.00029122233,0.00054440735,0.00009875171,0.00001615351,0.0006307391],"genre_scores_gemma":[0.9951125,0.003713773,0.00007133169,0.0007142533,0.00005644031,0.00010559021,0.00008946658,0.000054852822,0.000081799364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834687,0.00006495779,0.0002950498,0.00063398696,0.00021386902,0.00044526934],"domain_scores_gemma":[0.99939793,0.000009255299,0.000112125854,0.00029091333,0.00003668381,0.0001531046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006114665,0.00037094686,0.0002693461,0.000048384467,0.000076215394,0.00007594057,0.0001468409,0.0001706175,0.00003060628],"category_scores_gemma":[0.0000035356315,0.00034530906,0.00008797177,0.00008382622,0.00019326573,0.000020159137,0.0001584395,0.00017941624,0.000009971125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001681405,0.0002046007,0.0060018357,0.00006537506,0.00008582136,0.000030001249,0.0006714054,0.000077582794,0.99168336,0.000067746936,0.00007355404,0.00087059423],"study_design_scores_gemma":[0.0015556136,0.00021011427,0.0014834421,0.00007726672,0.000029139346,0.0000112379485,0.0012556714,0.000044536446,0.9926398,0.00004259879,0.0022053125,0.000445298],"about_ca_topic_score_codex":0.00023278226,"about_ca_topic_score_gemma":0.0000479667,"teacher_disagreement_score":0.012806858,"about_ca_system_score_codex":0.000029917033,"about_ca_system_score_gemma":0.00007996053,"threshold_uncertainty_score":0.99989986},"labels":[],"label_agreement":null},{"id":"W4248659508","doi":"10.1158/1538-7445.sabcs18-lb-269","title":"Abstract LB-269: Development of a vaccine model to track the CD8-specific response in Mauritius cynomolgus monkey","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nuclear Laboratories","funders":"","keywords":"CTL*; Immune system; CD8; Cytotoxic T cell; Immunology; Immunotherapy; Cancer immunotherapy; T cell; Medicine; Biology; In vitro","score_opus":0.019769505183821222,"score_gpt":0.27037863218729646,"score_spread":0.25060912700347526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248659508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626748,0.035856284,0.00031266978,0.00026360157,0.00015158523,0.0005092707,0.000007533623,0.000019366613,0.00020486096],"genre_scores_gemma":[0.9979311,0.00018358689,0.00044194222,0.00077404786,0.0000035423652,0.00004660817,0.00001162243,0.000029972523,0.0005775614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871904,0.00018483688,0.00041805612,0.00028701982,0.00006711788,0.00032391842],"domain_scores_gemma":[0.99941206,0.00009088798,0.000081808335,0.0003672544,0.00002766059,0.000020314828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034982964,0.00023593279,0.0002887054,0.00012519122,0.00010443222,0.000018147168,0.00025890773,0.00014907274,0.00015221824],"category_scores_gemma":[0.0000039674405,0.00017918069,0.00007877489,0.00012723793,0.00007735635,0.00005368887,0.000094303556,0.0002094485,0.00009164877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008060129,0.00031131707,0.00007593001,0.000007282327,0.00012731977,0.000006384357,0.008030268,0.00007773976,0.9772268,0.00020432736,0.000022854667,0.005849657],"study_design_scores_gemma":[0.0021274083,0.0003718937,0.0058269855,0.00004743219,0.0000067610476,0.000028638757,0.0017115463,0.000031493448,0.9679948,0.000035309637,0.02158853,0.00022921767],"about_ca_topic_score_codex":0.0000145097065,"about_ca_topic_score_gemma":0.0000018204292,"teacher_disagreement_score":0.0356727,"about_ca_system_score_codex":0.00005536211,"about_ca_system_score_gemma":0.00007712964,"threshold_uncertainty_score":0.73067766},"labels":[],"label_agreement":null},{"id":"W4256129842","doi":"10.1158/1538-7445.sabcs18-3925","title":"Abstract 3925: A screen for epigenetic radiosensitizers in small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Epigenetics; Cancer; Lung cancer; Computer science; Computational biology; Chemistry; Biology; Medicine; Oncology; Biochemistry; Genetics","score_opus":0.022115013067051548,"score_gpt":0.3432664170486949,"score_spread":0.3211514039816434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256129842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94973135,0.047047224,0.00009861403,0.00049382774,0.000081833736,0.0012249149,0.000012736757,0.000016959406,0.0012925616],"genre_scores_gemma":[0.9966873,0.00071831455,0.0006065468,0.0014239136,0.000039076975,0.0001219911,0.000010360701,0.00003333577,0.00035915777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991502,0.00001703371,0.00013960613,0.00025715973,0.00013788581,0.00029810722],"domain_scores_gemma":[0.99966824,0.000028471537,0.000030370304,0.00015774873,0.000031455173,0.00008371712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076668206,0.00014922737,0.00023004097,0.000063246065,0.000035410903,0.00001581504,0.00005274248,0.000054948567,0.0000380369],"category_scores_gemma":[0.00000210484,0.00012973296,0.000070881346,0.000066553126,0.00005990967,0.000019975574,0.00004548529,0.000108988206,0.0000035495718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003303304,0.00012530081,0.011426262,0.0001682405,0.0001481845,0.00003316841,0.0010853225,0.00001178591,0.98493016,0.000040882547,0.000053027223,0.0016473416],"study_design_scores_gemma":[0.004620343,0.0004310299,0.012825729,0.00013498758,0.000054675813,0.000007179095,0.0009784333,0.00067958,0.97737914,0.0000268848,0.0026537378,0.00020826817],"about_ca_topic_score_codex":0.00019350855,"about_ca_topic_score_gemma":0.000015007447,"teacher_disagreement_score":0.046955973,"about_ca_system_score_codex":0.00013731707,"about_ca_system_score_gemma":0.00007047518,"threshold_uncertainty_score":0.5290356},"labels":[],"label_agreement":null}]}